» Articles » PMID: 27142480

Microgravity Induction of TRAIL Expression in Preosteoclast Cells Enhances Osteoclast Differentiation

Overview
Journal Sci Rep
Specialty Science
Date 2016 May 5
PMID 27142480
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Evidence indicates that astronauts experience significant bone loss in space. We previously showed that simulated microgravity (μXg) using the NASA developed rotary cell culture system (RCCS) enhanced bone resorbing osteoclast (OCL) differentiation. However, the mechanism by which μXg increases OCL formation is unclear. RANK/RANKL signaling pathway is critical for OCL differentiation. Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) has been shown to increase osteoclastogenesis. We hypothesize that TRAIL may play an important role in μXg enhanced OCL differentiation. In this study, we identified by RT profiler PCR array screening that μXg induces high levels of TRAIL expression in murine preosteoclast cells in the absence of RANKL stimulation compared to ground based (Xg) cultures. We further identified that μXg elevated the adaptor protein TRAF-6 and fusion genes OC-STAMP and DC-STAMP expression in preosteoclast cells. Interestingly, neutralizing antibody against TRAIL significantly reduced μXg induced OCL formation. We further identified that over-expression of pTRAIL in RAW 264.7 cells enhanced OCL differentiation. These results indicate that TRAIL signaling plays an important role in the μXg increased OCL differentiation. Therefore, inhibition of TRAIL expression could be an effective countermeasure for μXg induced bone loss.

Citing Articles

TNF-Related Apoptosis-Inducing Ligand: Non-Apoptotic Signalling.

Guerrache A, Micheau O Cells. 2024; 13(6.

PMID: 38534365 PMC: 10968836. DOI: 10.3390/cells13060521.


Exosomes from Microvascular Endothelial Cells under Mechanical Unloading Inhibit Osteogenic Differentiation via miR-92b-3p/ELK4 Axis.

Zhang X, Zhang L, Xu L, Li G, Wang K, Xue T J Pers Med. 2022; 12(12).

PMID: 36556251 PMC: 9785449. DOI: 10.3390/jpm12122030.


Tetrandrine inhibits RANKL-induced osteoclastogenesis by promoting the degradation of TRAIL.

Li J, Li X, Zhou S, Wang Y, Lu Y, Wang Q Mol Med. 2022; 28(1):141.

PMID: 36435772 PMC: 9701442. DOI: 10.1186/s10020-022-00568-4.


Simulated Galactic Cosmic Rays Modify Mitochondrial Metabolism in Osteoclasts, Increase Osteoclastogenesis and Cause Trabecular Bone Loss in Mice.

Kim H, Richardson K, Krager K, Ling W, Simmons P, Allen A Int J Mol Sci. 2021; 22(21).

PMID: 34769141 PMC: 8583929. DOI: 10.3390/ijms222111711.


Juglanin Inhibits Osteoclastogenesis in Ovariectomized Mice via the Suppression of NF-κB Signaling Pathways.

Zhang F, Huang X, Qi Y, Qian Z, Ni S, Zhong Z Front Pharmacol. 2021; 11:596230.

PMID: 33708115 PMC: 7941268. DOI: 10.3389/fphar.2020.596230.


References
1.
Bernardi S, Milani D, Fabris B, Secchiero P, Zauli G . TRAIL as biomarker and potential therapeutic tool for cardiovascular diseases. Curr Drug Targets. 2012; 13(9):1215-21. DOI: 10.2174/138945012802002357. View

2.
Di S, Tian Z, Qian A, Li J, Wu J, Wang Z . Large gradient high magnetic field affects FLG29.1 cells differentiation to form osteoclast-like cells. Int J Radiat Biol. 2012; 88(11):806-13. DOI: 10.3109/09553002.2012.698365. View

3.
Brunetti G, Oranger A, Mori G, Sardone F, Pignataro P, Coricciati M . TRAIL effect on osteoclast formation in physiological and pathological conditions. Front Biosci (Elite Ed). 2011; 3(3):1154-61. DOI: 10.2741/e318. View

4.
Alexandre C, Vico L . Pathophysiology of bone loss in disuse osteoporosis. Joint Bone Spine. 2011; 78(6):572-6. DOI: 10.1016/j.jbspin.2011.04.007. View

5.
Weinreb M, Rodan G, Thompson D . Osteopenia in the immobilized rat hind limb is associated with increased bone resorption and decreased bone formation. Bone. 1989; 10(3):187-94. DOI: 10.1016/8756-3282(89)90052-5. View